Novacyt S.A. (NVYTF)

OTCMKTS · Delayed Price · Currency is USD
0.566
0.00 (0.00%)
At close: Dec 3, 2024
-21.17%
Market Cap 47.64M
Revenue (ttm) 23.46M
Net Income (ttm) -47.57M
Shares Out n/a
EPS (ttm) -0.67
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 200
Open 0.566
Previous Close n/a
Day's Range 0.566 - 0.566
52-Week Range 0.500 - 1.250
Beta -1.86
Analysts n/a
Price Target n/a
Earnings Date Dec 27, 2024

About Novacyt

Novacyt S.A., together with its subsidiaries, provides in vitro and molecular diagnostic tests for a range of infectious diseases in the United Kingdom, rest of Europe, France, the United States, the Asia Pacific, the Middle East, and Africa. It operates through Primer Design, and Yourgene Health segments. The Primer Design segment designs, manufactures, and markets molecular real-time qPCR testing devices and reagents in the areas of infectious diseases. The Yourgene Health segment delivers molecular diagnostic and screening solutions, across ... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2006
Employees 237
Stock Exchange OTCMKTS
Ticker Symbol NVYTF
Full Company Profile

Financial Performance

In 2023, Novacyt's revenue was 11.58 million, a decrease of -44.97% compared to the previous year's 21.04 million. Losses were -28.29 million, 9.96% more than in 2022.

Financial numbers in GBP Financial Statements

News

Novacyt SA (NVYTF) Q2 2024 Earnings Call Transcript Highlights: Key Financial Metrics and ...

Novacyt SA (NVYTF) Q2 2024 Earnings Call Transcript Highlights: Key Financial Metrics and Strategic Insights

2 months ago - GuruFocus

Half Year 2024 Novacyt SA Earnings Call Transcript

Half Year 2024 Novacyt SA Earnings Call Transcript

2 months ago - GuruFocus

Novacyt S.A. (NVYTF) Q4 2023 Earnings Call Transcript

Novacyt S.A. (OTCPK:NVYTF) Q4 2023 Earnings Conference Call May 30, 2024 6:00 AM ET Company Participants Lyn Rees - CEO Steve Gibson - CFO Conference Call Participants Operator [abrupt start] and welc...

6 months ago - Seeking Alpha

Novacyt S.A. (NVYTF) Q2 2023 Earnings Call Transcript

Novacyt S.A. (OTC:NVYTF) Q2 2023 Earnings Conference Call September 28, 2023 7:30 AM ET Company Participants James McCarthy - Acting CEO Steve Gibson - Group Finance Director Lyn Rees - Executive Dire...

1 year ago - Seeking Alpha

Novacyt S.A. (NVYTF) Q4 2022 Earnings Call Transcript

Novacyt S.A. (OTCPK:NVYTF) Q4 2022 Results Conference Call April 27, 2023 7:00 AM ET Company Participants James McCarthy - Acting Chief Executive Officer Steve Gibson - Group Finance Director Operator...

1 year ago - Seeking Alpha

Novacyt S.A. (NVYTF) Q2 2022 Earnings Call Transcript

Novacyt S.A. (OTCPK:NVYTF) Q2 2022 Earnings Conference Call September 29, 2022 7:00 AM ET Company Participants David Allmond - Chief Executive Officer James McCarthy - Chief Financial Officer Conferen...

2 years ago - Seeking Alpha

Novacyt S.A. ("Novacyt", the "Company" or the "Group"): Half Year 2022 Results

PARIS & CAMBERLEY, England--(BUSINESS WIRE)--Regulatory News: Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces its unaudited results for the ...

2 years ago - Business Wire